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In isolated porcine coronary arteries, the endothelium inhibits the 
contractions induced by serotonin and aggregating platelets. This 
effect is reduced by regeneration after balloon denudation. The 
present study was designed to examine whether those in vitro 
observations could be reproduced in vivo. Sixteen male Yorkshire 
pigs underwent balloon removal of the endothelium from either 
the left anterior descending (n = 9) or left circumflex (n = 7) 
coronary artery. An angiographic study was performed before 
and 4 weeks after endothelial denudation; in the latter condition 
the presence of a full endothelial lining was confirmed histologi-
cally. 
Before endothelial denudation, intracoronary injection of ser-
otonin (10 #LWkg) caused only mild constriction in both arteries. 
However, 4 weeks after the denudation, intracoronary serotonin 
In vitro studies (1,2) demonstrate the important role of the 
endothelium in modulating the responses of vascular smooth 
muscle to a variety of vasoactive agents. Among the possible 
physiologic roles of the endothelium, its inhibitory action 
against aggregating platelets and their products appears to be 
important (3-7). Indeed, aggregating platelets are an impor-
tant source of vasoconstrictor substances and have been 
regarded as one of the most likely causes for coronary 
vasospasm (8,9). The inhibitory effect of the endothelium 
against the contractions induced by serotonin and aggregat-
ing platelets is reduced in isolated porcine coronary arteries 
with regenerated endothelium that have recovered from 
previous balloon injury (5). The present study was designed 
to examine whether those in vitro observations could be 
reproduced in vivo. 
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repeatedly caused marked hyperconstriction in the previously 
denuded artery compared with the control coronary artery. 
Intracoronary injection of aggregating platelets stimulated by 
collagen caused constriction in the previously denuded artery but 
not in the control artery. The hyperconstriction induced by 
serotonin and aggregating platelets was inhibited by intravenous 
injection of ketanserin (a S-HT2-serotonergic blocker). 
These data indicate that 1) the normal endothelium blunts the 
coronary vasoconstriction induced by serotonin and aggregating 
platelets in vivo, and 2) the inhibitory effect of the endothelium is 
reduced after regeneration, allowing coronary hyperconstriction 
or vasospasm, or both. 
(J Am CoU CardioI1991j17:1197-202) 
Methods 
Sixteen male Yorkshire pigs (26.0 ± 0.4 kg) were used. 
They were housed individually in temperature-controlled 
animal quarters and were fed a regular chow (Hog Finisher, 
Bedtke Brothers Feed and Seed Co.) before and after the 
balloon endothelial denudation. All protocols described here 
were approved by the Committee of the Mayo Clinic on the 
Ethics of Animal Experiments. 
Coronary endothelial denudation. The pigs were anesthe-
tized with ketamine hydrochloride (300 mg intramuscularly, 
Bristol Laboratories) followed by sodium pentobarbital 
(12.5 mg/kg intravenously, Fort Dodge Laboratories). Using 
aseptic surgical techniques, the right carotid artery was 
dissected free and a specially designed coronary guide 
catheter was inserted into the left coronary ostium under 
fluoroscopic guidance (left anterior oblique projection). The 
electrocardiogram (ECG) (leads III and aVL) and arterial 
pressure were monitored continuously. The pigs were then 
given 20 mg of lidocaine HCI (Astra) and 100 U/kg of heparin 
(Elkins-Sinn) intravenously. A control left coronary angio-
gram was obtained and a balloon dilation catheter was 
selected according to the size of the coronary artery (3.0 to 
3.7 mm in diameter, 20 mm long; United States Catheter and 
Instruments). The dilation catheter was advanced through 
the guide catheter to either left anterior descending (n = 9) or 
left circumflex (n = 7) coronary artery and gently rubbed 
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against 3 cm of the proximal portion of the artery (5,7). The 
accuracy of this technique to remove the endothelium has 
been demonstrated previously (5). Before the denudation 
procedure, the balloon was kept inflated for 20 to 30 s to 
examine the ischemic ECG changes; ST-segment elevation 
(>0.1 m V) was noted in lead III and a VL when the balloon 
was inflated in the left circumflex and left anterior descend-
ing coronary artery, respectively, in this model. Precordial 
leads were not used for technical reasons. 
Coronary angiography. Angiography was performed be-
fore and 4 weeks after endothelial denudation. Before the 
denudation the effect of intracoronary injection of serotonin 
(10 JLg/kg) (Sigma Chemical) was examined in eight pigs, and 
after 4 weeks the effects of intracoronary injection of sero-
tonin (10 JLg/kg) (n = 16), aggregating platelets (obtained 
from autologous blood and stimulated by 5 mg collagen ex 
vivo [n = 6]) and intravenous injection of nitroglycerin 
(20 JLg/kg; n = 16) were tested. The doses of serotonin and 
nitroglycerin were chosen based on the previous studies 
(10-12). 
Left coronary angiograms were obtained during injection 
of 5 ml of meglumine diatrizoate (Renografin 76) into the left 
main coronary artery. Exposures were made at 85 to 95 kV, 
75 to 100 rnA for 35 ms, depending on body weight (5). 
The solution of serotonin or activated platelets was 
infused gradually for 1 min into the left main coronary 
artery. Left coronary angiograms were usually obtained 
2 min after completion of the injection or when the ischemic 
ECG changes (0.1 mV of ST segment elevation or depres-
sion) were noted. The order of serotonin and aggregating 
platelets was randomized. In six pigs, the effects of serotonin 
and aggregating platelets were reexamined after intravenous 
injection of a selective 5-HT 2-serotonergic blocker, ketan-
serin (1 mg/kg). Each drug trial and coronary angiography 
was performed at an interval of 20 to 30 min; by that time the 
coronary artery diameter had returned to baseline. 
Angiograms were analyzed in a blinded manner for cor-
onary dimensions along the proximal 3 cm of the artery at 
every 0.1 mm using a computer-based quantitative angio-
graphic system (5,13). The accuracy of this system was 
determined previously (13). The changes in coronary artery 
dimensions were expressed as percent changes from those in 
the control angiogram. Although serotonin and aggregating 
platelets usually caused uniform (diffused) responses in 
epicardial coronary arteries, they caused nonuniform re-
sponses in some previously denuded arteries. Therefore, the 
responses of previously denuded arteries were reported as 
maximal and mean percent changes of coronary artery 
diameter. 
Platelets. Blood (300 ml) for autologous platelet prepara-
tion was collected from the right femoral artery into citrate 
anticoagulant under anesthesia with ketamine hydrochlo-
ride; the collection was made twice, I and 2 h before the 
angiographic study. The citrated blood was centrifuged for 
40 min at 50 rpm and the platelet-rich plasma was pipetted 
off. The remaining blood cells were returned to the pig each 
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time. An equal volume of citrate anticoagulant solution was 
added to the platelet-rich plasma and the mixture was 
centrifuged for 20 min at 1,600 rpm. The supernatant was 
discarded and the remaining platelet pellet was resuspended 
in a small volume «10 ml) of the citrate anticoagulant 
mixture. A platelet count of this suspension was then ob-
tained (Coulter Electronics). This platelet solution was then 
mixed with 5 mg of collagen (Sigma Chemical) ex vivo for 
2 min to allow maximal platelet aggregation (14). After 0.5 ml 
of the platelet solution was separated for determination of 
serotonin concentration, the remaining solution was injected 
slowly over 1 min into the left main coronary artery. The 
separated platelet solution (0.5 ml) was added to 120 JLl of 
cysteine (1% by weight by distilled water) and proteins were 
precipitated by adding ZnS04 and NaOH and centrifuging at 
1,400 g for 30 min. The reSUlting supernatant was frozen for 
later analysis. The serotonin concentration in the superna-
tant was quantitated by reverse-phase high pressure liquid 
chromatography (5). 
Statistical analysis. Sequential data were analyzed by 
analysis of variance and paired data were analyzed by 
Student's t test. A p value of <5% was considered statisti-
cally significant. Results were expressed as mean ± SEM. 
Results 
Coronary angiography before and immediately after endo-
thelial denudation. Before balloon endothelial denudation, 
the diameters of the control artery (3.7 ± 0.1 mm) and the 
artery to be denuded (3.8 ± 0.1 mm) were comparable. 
Intracoronary injection ofthe diluent (1 ml physiologic saline 
solution) had no effects on coronary diameters, hemodynam-
ics or ECG (n = 8). Intracoronary injection of serotonin 
(10 JLg/kg) caused comparable vasoconstriction in the control 
artery (12 ± 4%) and the artery to be denuded (13 ± 4%) 
(n = 8). Heart rate (120 ± 10 beats/min) and blood pressure 
(146 ± 24/90 ± 12 mm Hg) did not change significantly with 
this intracoronary injection of serotonin and no ECG 
changes were noted. Immediately after endothelial denuda-
tion, the denuded artery constricted significantly (19 ± 3%, 
p < 0.05), whereas the control artery did not (4 ± 2% 
dilatation) (n = 16). This vasoconstriction related to endo-
thelial denudation was reversed by intravenous administra-
tion of 1 mg/kg of ketanserin (from 17 ± 5% vasoconstriction 
immediately after denudation to 3 ± 4% vasoconstriction 
after ketanserin, p < 0.05, n = 8); nitroglycerin (20 JLg/kg, 
intravenously) caused a slight further dilation (from 3 ± 4% 
vasoconstriction before to 0 ± 4% diameter change after 
nitroglycerin, n = 8). In the control artery intravenous 
ketanserin caused slight but significant dilation (from 1 ± 2% 
vasoconstriction to 5 ± 1 % dilation, n = 8) and no further 
dilation was noted with nitroglycerin (5 ± 2% dilatation, 
n = 8). 
Coronary angiography 4 weeks after endothelial denuda-
tion. After 4 weeks of maintenance, the body weight in-
creased significantly to 38.6 ± 0.6 kg. Heart rate (118 ± 12 
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beats/min) and blood pressure (150 ± 22/92 ± 10 mm Hg) 
were not different from values before coronary endothelial 
denudation. 
The coronary artery diameter under control conditions 
was 4 ± 0.1 mm in the control artery and 4 ± 0.1 mm in the 
previously denuded artery (n = 16; P = NS). Angiographi-
cally, no stenotic lesions were noted in either artery; the 
ECG (leads III and a VL) was normal. Intracoronary injec-
tion of the diluent (I ml physiologic saline solution) had no 
effects on coronary diameters, hemodynamics or ECG (n = 
16). Intracoronary injection of serotonin (10 1Lg/kg) caused 
marked constriction in the previously denuded artery com-
pared with the control artery (Fig. 1 and 2). This hypercon-
striction was associated with ischemic ECG changes (coro-
nary vasospasm) in the spastic myocardial area (7 of 16 
cases, ST segment elevation in 3 and ST segment depression 
in 4). The ischemic ECG changes were observed in leads III 
and a VL when the hyperconstriction was induced in the left 
circumflex and the left anterior descending coronary arter-
ies, respectively. Coronary spasm with ischemic ECG 
changes started 30 s to 1 min after completion of intracoro-
nary injection of serotonin, lasted from 30 s to 3 min and 
disappeared spontaneously. The heart rate increased (136 ± 
16 beats/min) slightly but significantly and blood pressure did 
not change. These phenomena could be induced repeatedly. 
Intracoronary injection of aggregating platelets also 
caused constriction in the previously denuded but not in the 
control artery (Fig. 1 and 3). Intracoronary injection of 
collagen (5 mg) alone had no significant effect in either artery 
(n = 6). The time course of the platelet-induced hypercon-
striction was similar to that induced by serotonin. However, 
no ischemic ECG or hemodynamic changes were noted. 
After intravenous treatment with ketanserin (1 mg/kg) , 
the vasoconstrictor effects of serotonin and aggregating 
platelets were reexamined. In the previously denuded 
SHIMOKA WA AND V ANHOUTIE 
CORONARY HYPERCONSTRICTION AND ENDOTHELIUM 
Serotonin 
Aggregating 
platelets 
1199 
Figure 1. Left coronary angiograms from a pig that underwent 
coronary endothelial denudation of the proximal portion of the left 
circumflex coronary artery 4 weeks before the experiment. Left, 
Control. Middle, Serotonin (10 jLg/kg intracoronary injection). 
Right, Aggregating platelets (activated by 5 mg collagen). Note that 
vasospasm and hyperconstriction were induced by serotonin and 
aggregating platelets, respectively, along the previously denuded 
portion of the left circumflex coronary artery. The electrocardio-
gram after serotonin shows evidence of ischemia. 
artery, ketanserin significantly inhibited the hyperconstric-
tion or spasm induced by serotonin and aggregating plate-
lets, or both (Fig. 3). In contrast, in the control artery 
pretreatment with ketanserin abolished the vasoconstriction 
to serotonin and converted the response to aggregating 
Figure 2. Responses of control (left) and previously denuded artery 
(right) to intracoronary injection of serotonin (10 p,g/kg). The 
responses are expressed as percent change in coronary artery 
diameter from that in control condition. *p < 0.05 compared with 
control artery; tp < 0.05 compared with no treatment with ketan-
senn. 
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Figure 3. Responses of control (left) and previously denuded arter-
ies (right) to intracoronary injection of aggregating platelets. The 
responses are expressed as percent change in coronary artery 
diameter from that in control condition. *p < 0.05 compared with 
control artery; tp < 0.05 compared with no treatment with ketan-
serino 
platelets to dilation (Fig. 3). Nitroglycerin caused compara-
ble dilation in the control (5 ± 1%) and the previously 
denuded (6 ± 1 %) artery (n = 16). 
Serotonin released from aggregating platelets. The seroto-
nin concentration in the activated platelet solution was 2.6 ± 
OJ /-Lgl109 platelets (n = 6). Because preliminary study 
demonstrated that the plasma concentration of serotonin in 
pig arterial blood (ascending aorta) under control conditions 
averaged 47 nglml (n .= 5), about 90% of the serotonin 
detected in the platelet solution must originate from the 
aggregating platelets on stimulation by collagen. The platelet 
solution contained 6.2 ± 0.7 x 1010 platelets. Thus, the 
estimated amount of serotonin injected into the left main 
coronary artery was 161 ± 18 /-Lg (n = 6) (approximately 
4/-Lglkg). 
Histology. After angiographic study, histologic examina-
tion was performed on the myocardium and coronary arter-
ies with no myocardial infarction noted. In both control and 
previously denuded arteries, the endothelium covered all 
inner surfaces of the vessels. Only at the previously denuded 
portion of the artery, an eccentric, mild «OJ mmz) intimal 
thickening was noted, as reported previously (5). 
Discussion 
The present study is in agreement with our previous in 
vitro observations (5) and demonstrates that the normal 
endothelium reduces the coronary vasoconstriction induced 
by serotonin and aggregating platelets in vivo; the inhibitory 
effects of the endothelium are reduced after regeneration 
after injury, which favors the occurrence of coronary hyper-
constriction or vasospasm, or both. 
Serotonin and the endothelium. Serotonin possesses both 
direct activating and endothelium-dependent inhibitory ef-
fects on vascular smooth muscle (2,4,15,16). In porcine 
JACC Vol. 17, No.5 
April 1991:1197-202 
coronary arteries the former is mediated by 5-HTz-
serotonergic receptors on the vascular smooth muscle, and 
the latter by 5-HTJ-serotonergic receptors on the endothe-
lium (5). In the present study ketanserin, a 5-HTz-
serotonergic blocker (17), significantly inhibited the coro-
nary vasoconstriction induced by serotonin, indicating that 
also in vivo the monoamine causes constriction of porcine 
coronary arteries by acting on 5-HTz-serotonergic receptors. 
Although serotonin was not tested immediately after endo-
thelium removal in the present study, previous experiments 
(13,18) demonstrate that the vasoconstriction evoked by the 
monoamine is enhanced after acute endothelial injury with 
balloon catheters similar to those used in the present study. 
This enhanced responsiveness can be explained by a loss of 
the inhibitory effects of the endothelium and the resultant 
expression of direct activation of the smooth muscle by 
serotonin. 
In the previously denuded artery with regenerated endo-
thelium, the vasoconstrictor response to serotonin was en-
hanced markedly, which resulted in the occurrence of myo-
cardial ischemia (coronary vasospasm). This finding is in 
agreement with the previous in vitro observation (5) that the 
endothelium-dependent inhibition against serotonin-induced 
contractions is significantly reduced in porcine coronary 
arteries with regenerated endothelium. The in vitro studies 
indicated that the reduced inhibitory effect of the regener-
ated endothelium is due mainly to reduced production of 
endothelium-derived relaxing factor, although the concomi-
tant production of endothelium-derived contracting factor in 
response to higher concentrations of the monoamine is a 
contributing factor (5). Under these conditions the ability of 
the vascular smooth muscle to contract in response to 
serotonin or to relax in response to sodium nitroprusside 
(which activates soluble guanylate cyclase of vascular 
smooth muscle as does endothelium-derived relaxing factor 
[19]) was unaltered (5). A signal-transduction system medi-
ated by an endothelial pertussis toxin-sensitive G protein is 
involved in the serotonin-induced release of endothelium-
derived relaxing factor (20), and the dysfunction of this G 
protein may account in part for the changes in endothelial 
responsiveness observed in the chronic regenerated state 
(21). The endothelium-dependent inhibition of serotonin-
induced contractions is impaired further in atherosclerotic 
porcine coronary arteries (7) in which coronary vasospasm 
can be repeatedly provoked by the monoamine in vivo 
(10,11). 
Aggregating platelets and the endothelium. Endothelium-
dependent relaxation responses to aggregating platelets have 
been observed in isolated coronary arteries in dogs (3,4), 
pigs (5,7) and recently in humans (22). Endothelium-
dependent responses to aggregating platelets are the global 
expression of divergent reactions (relaxations and contrac-
tions) to several released platelet products and their interac-
tions (8,9). In porcine coronary arteries platelet-induced 
release of endothelium-derived relaxing factor is mediated 
by both 5-HTJ-serotonergic and purinergic (adenosine 
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diphosphate [ADP]) receptors on the endothelium, whereas 
platelet-induced vasoconstriction was significantly inhibited 
by ketanserin, indicating an important role of platelet-
derived serotonin in the response. Among the porcine arter-
ies studied, the endothelium-dependent relaxation to aggre-
gating platelets is most pronounced in the coronary artery 
(23); therefore, in this blood vessel platelet-induced contrac-
tions are prevented most effectively by the presence of 
normal endothelium (5). Indeed, in the present study aggre-
gating platelets caused no vasoconstriction in control coro-
nary arteries with normal endothelium, indicating that under 
normal conditions the constriction and relaxation induced by 
platelet-derived vasoactive substances are well balanced 
(5-9). In the isolated rabbit heart addition of activated 
platelets to the perfusion solution causes constriction of 
epicardial coronary arteries only after the endothelium has 
been removed (24). 
This study indicates that the endothelium exerts its inhib-
itory actions on platelet-induced constriction under normal 
conditions but that endothelial injury results in platelet 
aggregation and constriction by platelet products. Immedi-
ately after endothelial denudation, a significant vasoconstric-
tion was noted only in the denuded portion of the coronary 
artery; this vasoconstriction was reversed by ketanserin, 
suggesting that platelet-derived serotonin plays an important 
role in this immediate response to endothelial injury. A 
positive correlation exists between the extent of platelet 
deposition and that of vasoconstriction soon after balloon 
angioplasty in porcine carotid arteries (25). 
In the previously denuded artery with regenerated endo-
thelium, aggregating platelets caused vasoconstriction. This 
finding is in agreement with in vitro observations (5) that the 
endothelium-dependent inhibition of platelet-induced con-
tractions is reduced in coronary arteries covered with regen-
erated endothelial cells. The platelet-induced vasoconstric-
tion, however, was less than that induced by serotonin and 
no myocardial ischemia was induced. Obviously, this is 
partly because that amount of serotonin contained in the 
platelet solution was <10 JLg/kg, as indicated by measure-
ment of the monoamine, and partly because endothelium-
dependent relaxation to platelet-derived adenine nucleotides 
(ADP and adenosine triphosphate [ATP]) remains normal in 
the present model, counteracting the serotonin-induced 
vasoconstriction (5,9). Larger amounts of aggregating plate-
lets were not tested because of the limited availability of 
autologous blood. However, aggregating platelets cause 
constriction only in arteries with dysfunctional endothelium. 
In atherosclerotic coronary arteries, where the inhibitory 
effects of the endothelium are impaired further (including an 
impaired relaxation to adenine nucleotides) (7), aggregating 
platelets probably cause more intense vasoconstriction and 
eventually initiate vasospasm. 
Clinical implications. The present in vivo findings in the 
pig may be relevant clinically because endothelial turnover is 
markedly accelerated in hyperlipidemia (26) and hyperten-
sion (27) as a result of continuous endothelial injury; the 
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vasoconstrictor responses to serotonin are enhanced under 
those pathologic conditions (10,11,28-30). Endothelium-
dependent relaxation progressively worsens rather than re-
covers after regeneration of the endothelium (21). In the 
present study coronary vasospasm and hyperconstriction 
were provoked in previously denuded arteries with regener-
ated endothelium in the absence of hypertension or hyper-
lipidemia. These findings suggest an important role for 
endothelial injury and subsequent tissue repair (including 
endothelial regeneration) in the pathogenesis of coronary 
vasospasm. 
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